Manning Paul B
- SEC CIK
- 0001494695
In the past year, 2 open-market purchase filings worth $20.5M and 1 sale filing worth $12.8M.
Current role at each company
- CADL Candel Therapeutics, Inc.Directoras of Jul 1, 2026
- LQDA Liquidia CorpDirectoras of Jun 18, 2026
- VRCA Verrica Pharmaceuticals Inc.Director, 10% Owneras of Nov 25, 2025
- TSHA Taysha Gene Therapies, Inc.10% Owneras of Jun 3, 2025
- ABOS Acumen Pharmaceuticals, Inc.10% Owneras of Jul 8, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $20.5M
- 2 filings
- Sold
- $12.8M
- 1 filing
- Net
- +$7.71M
- Bought minus sold
- Companies
- 3
- With open-market trades
Trades
Every Form 4 that lists Manning Paul B as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
LQDA Liquidia Corp
Director5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 8, 2026 (view filing) | Jun 4 | 4 days | Manning Paul BDirector | SSale | −200.0K | $63.91 | −$12.8M | −20.0%798.3K after | 5 lots |
| Sep 2, 2025 (view filing) | Aug 28-Sep 2 | 5 days | Manning Paul BDirector | SSale | −670.8K | $28.26 | −$19.0M | −60.9%430.8K after | 4 lots |
| Sep 16, 2024 (view filing) | Sep 12 | 4 days | Manning Paul BDirector | PPurchase | +337.1K | $8.90 | +$3.00M | +70.3%816.3K after | |
| Dec 18, 2023 (view filing) | Dec 14 | 4 days | Manning Paul BDirector | PPurchase | +279.3K | $7.16 | +$2.00M | New position279.3K after | |
| Apr 19, 2022 (view filing) | Apr 18 | 1 day | Manning Paul BDirector | PPurchase | +392.2K | $5.10 | +$2.00M | New position392.2K after |
CADL Candel Therapeutics, Inc.
Director4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 26, 2026 (view filing) | Feb 23 | 3 daysLate | Manning Paul BDirector | PPurchase | +550.5K | $5.45 | +$3.00M | +24.9%2.76M after | |
| Dec 18, 2024 (view filing) | Dec 16 | 2 days | Manning Paul BDirector | PPurchase | +1.25M | $6.00 | +$7.50M | +2,325.5%1.30M after | 2 lots |
| Aug 4, 2021 (view filing) | Jul 29 | 6 days | Manning Paul BDirector, 10% Owner | PPurchase | +1.63M | $8.00 | +$13.0M | +2,901.8%1.68M after | Amended |
| Jul 29, 2021 (view filing) | Jul 27-29 | 2 days | Manning Paul BDirector | PPurchase | +56.0K | $7.34 | +$411.0K | New position56.0K after | 2 lots |
VRCA Verrica Pharmaceuticals Inc.
Director, 10% Owner11 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 25, 2025 (view filing) | Nov 25 | Same day | Manning Paul BDirector, 10% Owner | PPurchase | +1.38M | $4.24 | +$5.83M | +53.3%3.96M after | |
| Nov 25, 2025 (view filing) | Nov 25 | Same day | Manning Paul BDirector, 10% Owner | PPurchase | +2.75M | $4.24 | +$11.7M | +460.3%3.35M after | |
| Nov 25, 2025 (view filing) | Nov 25 | Same day | Manning Paul BDirector, 10% Owner | PPurchase | +343.8K | – | – | –343.8K after | Derivative |
| Nov 25, 2025 (view filing) | Nov 25 | Same day | Manning Paul BDirector, 10% Owner | PPurchase | +687.7K | – | – | –687.7K after | Derivative |
| Nov 26, 2024 (view filing) | Nov 22 | 4 days | Manning Paul BDirector, 10% Owner | PPurchase | +18.4M | – | – | +234.7%26.3M after | |
| Nov 26, 2024 (view filing) | Nov 22 | 4 days | Manning Paul BDirector, 10% Owner | PPurchase | +4.49M | – | – | +303.3%5.98M after | |
| Nov 26, 2024 (view filing) | Nov 22 | 4 days | Manning Paul BDirector, 10% Owner | PPurchase | +18.4M | – | – | –9.21M after | Derivative2 lots |
| Nov 26, 2024 (view filing) | Nov 22 | 4 days | Manning Paul BDirector, 10% Owner | PPurchase | +4.49M | – | – | –2.25M after | Derivative2 lots |
| Jul 24, 2023 (view filing) | Jul 24 | Same day | Manning Paul BDirector, 10% Owner | PPurchase | +200.0K | $5.02 | +$1.00M | +2.6%7.85M after | |
| Jul 5, 2022 (view filing) | Jul 5 | Same day | Manning Paul BDirector, 10% Owner | PPurchase | +4.76M | $2.10 | +$10.0M | +53.6%13.7M after |
TSHA Taysha Gene Therapies, Inc.
10% Owner9 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 3, 2025 (view filing) | May 30 | 4 days | Manning Paul B10% Owner | PPurchase | +750.0K | $2.75 | +$2.06M | +35.9%2.84M after | |
| Jul 1, 2024 (view filing) | Jun 27 | 4 days | Manning Paul B10% Owner | PPurchase | +1.33M | $2.25 | +$3.00M | New position1.33M after | |
| Nov 20, 2023 (view filing) | Nov 17 | 3 days | Manning Paul B10% Owner | PPurchase | +100.0K | $1.63 | +$163.0K | +0.6%16.6M after | |
| Aug 16, 2023 (view filing) | Aug 16 | Same day | Manning Paul B10% Owner | PPurchase | +16.5M | $0.90 | +$14.8M | New position16.5M after | |
| Nov 2, 2022 (view filing) | Oct 31 | 2 days | Manning Paul BDirector, 10% Owner | PPurchase | +1.50M | $2.00 | +$3.00M | +1,054.8%1.64M after | |
| Feb 4, 2022 (view filing) | Feb 2-3 | 2 days | Manning Paul BDirector, 10% Owner | PPurchase | +108.0K | $7.80 | +$842.7K | +315.8%142.2K after | 2 lots |
| Feb 4, 2022 (view filing) | Feb 2-3 | 2 days | Manning Paul BDirector, 10% Owner | PPurchase | +93.6K | $7.79 | +$729.1K | +4.7%2.09M after | 3 lots |
| Nov 29, 2021 (view filing) | Nov 24 | 5 days | Manning Paul BDirector, 10% Owner | PPurchase | +2.20K | $13.19 | +$29.0K | +6.9%34.2K after | |
| Nov 24, 2021 (view filing) | Nov 23 | 1 day | Manning Paul BDirector, 10% Owner | PPurchase | +20.0K | $12.54 | +$250.8K | +166.7%32.0K after |
ABOS Acumen Pharmaceuticals, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 8, 2021 (view filing) | Jul 6 | 2 days | Manning Paul B10% Owner | PPurchase | +312.5K | $16.00 | +$5.00M | +10.3%3.35M after | Duplicate filing |